Page last updated: 2024-12-07

r 61837

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

R 61837: antirhinovirus cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127504
CHEMBL ID1233737
SCHEMBL ID992823
MeSH IDM0160622

Synonyms (22)

Synonym
CHEMBL1233737
r-61837
3-methoxy-6-[4-(m-tolyl)piperazin-1-yl]pyridazine
5-(trifluoromethyl)-3-[3,5-dimethyl-4-[[3-(3-methyl-5-isoxazolyl)propyl]oxy]phenyl]-1,2,4-oxadiazole
r 61837
JEN ,
3-methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine
DB08017
3-methoxy-6-[4-(3-methylphenyl)piperazin-1-yl]pyridazine
pyridazine, 3-methoxy-6-(4-(3-methylphenyl)-1-piperazinyl)-
3-methoxy-6-(4-(3-methylphenyl)-1-piperazinyl)pyridazine
100241-46-1
unii-hk76he61aq
hk76he61aq ,
DDOAUTHWSCUHQA-UHFFFAOYSA-N
SCHEMBL992823
DTXSID30143050
r61837
3-methoxy-6-(4-(3-methylphenyl)piperazin-1-yl)pyridazine
Q27097247
3-methoxy-6-(4-(m-tolyl)piperazin-1-yl)pyridazine
AKOS040747335
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1562994Antiviral activity against Rhinovirus at 32 uM relative to control2019European journal of medicinal chemistry, Sep-15, Volume: 178Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's6 (54.55)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.85 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]